
Loading, please wait...

Loading, please wait...

Understanding e-cigarette adverse symptoms is essential for clinicians who guide patients through tobacco cessation. A recent secondary analysis of the ESTxENDS trial examined how these symptoms change over six months. Researchers followed 622 participants to determine the safety and tolerability of nicotine freebase e-cigarettes. Notably, the study focused on exclusive e-cigarette users to track specific health outcomes and their impact on long-term abstinence.
The trial revealed that many users experience initial discomfort when switching from tobacco. After the first week, 34% of exclusive users reported dry mouth. Additionally, 23% noted mouth or throat irritation, while 25% experienced a cough. Consequently, these side effects represent common barriers during the early stages of smoking cessation. However, the data suggests that these issues generally resolve with continued use.
By the six-month mark, the proportion of reported symptoms decreased significantly. Dry mouth reports fell to 18%, and cough decreased to 12%. Furthermore, mouth and throat irritation affected only 11% of users. This trend suggests that the body adapts to the aerosolized nicotine or propylene glycol over time. Specifically, continuous use of the device helped resolve dry mouth in a significant number of participants.
Interestingly, the study identified a link between persistent symptoms and smoking re-initiation. Specifically, participants who struggled with mouth or throat irritation were more likely to return to tobacco cigarettes. Therefore, addressing these early side effects is crucial for long-term cessation success. Clinicians should monitor these symptoms closely to prevent patients from relapsing. Moreover, providing clear expectations about initial discomfort may improve patient adherence to cessation programs.
During the first week of use, the most frequent reports include dry mouth, mouth or throat irritation, and coughing. These are often attributed to the propylene glycol and nicotine content in the e-liquid.
Yes, research shows that most symptoms decrease significantly over six months. For instance, the prevalence of cough and mouth irritation halved during the study period for exclusive users.
Notably, the trial found that mouth and throat irritation were primary drivers for smoking re-initiation. Patients experiencing these symptoms may require adjusted devices or e-liquids to remain smoke-free.
Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A secondary analysis of the ESTxENDS trial reveals that e-cigarette side effects diminish over time, though mouth irritation can trigger smoking re-initiati...
6 months ago

A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today